Vonoprazan Fumarate API Market to Reach USD 5.53 Billion by 2035 at 14.51% CAGR
Vonoprazan Fumarate API Market Overview The **Vonoprazan Fumarate API Market** is experiencing robust growth due to the increasing prevalence of acid-related gastrointestinal disorders, growing demand for advanced acid-suppression therapies, and continued pharmaceutical innovation. Vonoprazan, a potassium-competitive acid blocker (P-CAB), is gaining attention as an alternative to traditional proton pump inhibitors because of its rapid and … Read more